News

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...
Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. Regeneron ...
The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...
Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...
Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.
Learn about nasal polyps a condition that can be mistaken for a common cold and how to identify and treat them effectively ...
We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...